总结１９８９～１９９２年经化疗与肿瘤细胞缩减术（简称减瘤术）治疗２６例Ⅲ、Ⅳ卵巢癌患者的临床资料．结果显示对晚期卵巢癌病人酌情给予术前化疗有利于提高减瘤术的成功率，术后辅助多疗程联合化疗可延长生存期，改善预后．本文对手术与化疗的配合，术前化疗的选择和减瘤术的适应症及残余瘤与生存关系进行了探讨． To summarize the clinical data of 26 patients with stage Ⅲ and Ⅳ ovarian cancer who underwent chemotherapy and tumor cell reduction from 1989 to 1992. The results show that patients with advanced ovarian cancer, as appropriate, preoperative chemotherapy is conducive to improve the success rate of tumor reduction surgery, postoperative adjuvant multi-course chemotherapy combined with prolong survival and improve prognosis. This article discusses the cooperation between surgery and chemotherapy, the choice of preoperative chemotherapy and the indications of tumor reduction and the relationship between residual tumor and survival.